{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:22:56Z","timestamp":1791411776847,"version":"4.3.3"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00051\/2020"],"award-info":[{"award-number":["UIDB\/00051\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00051\/2020"],"award-info":[{"award-number":["UIDP\/00051\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2023,1]]},"abstract":"Abstract<\/jats:title>\n \n Aim<\/jats:title>\n To perform a post hoc analysis of the FIGHT trial, evaluating the effect of liraglutide (vs. placebo) on the totality of events in patients with heart failure with reduced ejection fraction (HFrEF).<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods<\/jats:title>\n FIGHT was a double\u2010blind randomized controlled trial (RCT) that studied liraglutide versus placebo in 300 recently hospitalized patients with HFrEF followed for 180\u2009days. The main outcome of the present analysis was total events of hospitalizations for heart failure (HF) or all\u2010cause death. Secondary outcomes included total arrhythmic events and prespecified total events of interest (arrhythmias, sudden cardiac death, acute coronary syndrome, worsening HF, cerebrovascular event, venous thromboembolism, lightheadedness, presyncope\/syncope or worsening renal function). Treatment effect was evaluated with negative binomial regression.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Compared to placebo, there was a trend towards increased risk with liraglutide of total HF hospitalizations or all\u2010cause deaths (96 vs. 143 events, incidence rate ratio [IRR] 1.41, 95% confidence interval [CI] 0.98\u20102.04;\n P<\/jats:italic>\n \u00a0=\u20090.064) and total arrhythmias (21 vs. 39, IRR 1.76, 95% CI 0.92\u20103.37;\n P<\/jats:italic>\n \u00a0=\u20090.088). Total prespecified events of interest were increased with liraglutide compared to placebo (196 vs. 295, IRR 1.43, 95% CI 1.06\u20101.92;\n P<\/jats:italic>\n \u00a0=\u20090.018). The risk of HF hospitalizations or all\u2010cause deaths with liraglutide was higher among patients in New York Heart Association (NYHA) Class III to IV (IRR 1.86, 95% CI 1.21\u20102.85) than in those in NYHA Class I to II (IRR 0.62, 95% CI 0.31\u20101.23; interaction\n P<\/jats:italic>\n \u00a0=\u20090.008), and among patients with diabetes (interaction\n P<\/jats:italic>\n \u00a0=\u20090.051). The risk of arrhythmic events was higher among those without an implanted cardiac device (interaction\n P<\/jats:italic>\n \u00a0=\u20090.047).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n In patients with HFrEF, liraglutide might increase the risk of cardiovascular adverse effects, an effect possibly driven by excess risk of arrhythmias and worsening HF events. As this was a post hoc analysis, these results should be interpreted as exploratory and hypothesis\u2010generating. Further RCTs must be conducted before drawing definitive conclusions.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/dom.14862","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T08:52:10Z","timestamp":1662713530000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the\n FIGHT<\/scp>\n trial"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8173-8255","authenticated-orcid":false,"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"first","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal"},{"name":"Department of Endocrinology, Diabetes and Metabolism Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vasques\u2010N\u00f3voa","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal"},{"name":"Department of Internal Medicine Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-3751","authenticated-orcid":false,"given":"Marta","family":"Borges\u2010Canha","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal"},{"name":"Department of Endocrinology, Diabetes and Metabolism Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Leite","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Cardiology, DREAM\u2010CV Lab McGill University Health Centre Montreal Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-3741","authenticated-orcid":false,"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o Porto Portugal"},{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-2387","authenticated-orcid":false,"given":"Milton","family":"Packer","sequence":"additional","affiliation":[{"name":"Baylor Heart and Vascular Institute Baylor University Medical Center Dallas Texas USA"},{"name":"Imperial College London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurith\u00e9matique 14\u201033, and Inserm U1116, CHRU Nancy, F\u2010CRIN INI\u2010CRCT (Cardiovascular and Renal Clinical Trialists) Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelino","family":"Leite\u2010Moreira","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal"},{"name":"Department of Cardiothoracic Surgery Centro Hospitalar Universit\u00e1rio S\u00e3o Jo\u00e3o Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal"},{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurith\u00e9matique 14\u201033, and Inserm U1116, CHRU Nancy, F\u2010CRIN INI\u2010CRCT (Cardiovascular and Renal Clinical Trialists) Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000920"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00203-5"},{"issue":"1","key":"e_1_2_8_4_1","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20102022","volume":"45","author":"Draznin B","year":"2022","journal-title":"Diabetes Care"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.037"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.009"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1047"},{"issue":"1","key":"e_1_2_8_8_1","first-page":"S144","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20102022","volume":"45","author":"Draznin B","year":"2022","journal-title":"Diabetes Care"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10260"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.657"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2016.01.008"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.000346"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.033065"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1934"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/hh1701.095716"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1193"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-6"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/hh2301.100003"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510113103"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-014-1515-1"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00434-3"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045888"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.12.1184"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111213252103"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.09.010"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03062"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/L20-0041"},{"key":"e_1_2_8_28_1","article-title":"Meta\u2010analysis of cardiovascular outcome trials assessing the impact of glucagon\u2010like peptide\u20101 receptor agonists on major cardiac arrhythmias","volume":"14","author":"Boulmpou A","year":"2022","journal-title":"Acta Cardiol"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.041659"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13955"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.063"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612917"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31149-3"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy565.P2518"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028365"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01366-8"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1113"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01687-1"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-318242"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14707"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.14862","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.14862","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.14862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:30:19Z","timestamp":1761877819000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.14862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1111\/dom.14862"],"URL":"https:\/\/doi.org\/10.1111\/dom.14862","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/review7","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/review4","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/review5","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/review6","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14862\/v2\/review3","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"2022-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}